Pain Is Not Where You Think It Is

hypnosis, integration, think, future, sculpture, model, powerless, pain, Derek lost his left leg below the knee in a motorcycle accident on a Tuesday in October. By the following Monday he was back in the hospital — not for infection, not for complications — because his missing foot was on fire. He could feel it. Not metaphorically. Not as an echo of memory.

He could feel specific toes on a foot that no longer existed, feel them burning, feel them cramping into positions that made him grip the bed rails. His neurologist, not given to dramatic statements, told him his brain was doing something extraordinary. “Your nervous system,” she said, “is very committed to the idea that you still have a foot.”

Derek’s experience isn’t rare. Between 60 and 80 percent of amputees experience phantom limb pain — pain in a body part that no longer exists. Widely known in medical circles. What’s less widely understood is why it happens, how it happens, and what it reveals about the nature of pain itself — one of the more illuminating stories in modern neuroscience.

A story about how the brain constructs reality, how that construction can go catastrophically wrong, and how understanding those failures might reveal treatments not just for phantom pain but for chronic pain of every kind.


PAIN IS NOT WHERE YOU THINK IT IS

The most important thing to understand about phantom pain — and about pain in general — is that pain doesn’t exist in the body. It exists in the brain.

Not a philosophical proposition. A neurological fact with enormous practical consequences.

When you stub your toe, nociceptors in the toe detect tissue damage and fire electrical signals through peripheral nerves to the spinal cord. From there, signals travel to the brainstem, the thalamus, and finally the cortex, where they’re processed, integrated with memory, emotion, expectation, and ultimately transformed into the experience called pain.

The pain, at every point in that chain, is a construction — a model of bodily threat the brain generates from available evidence. The toe provides data. The brain produces the experience.

This distinction matters because it explains phantom pain immediately. When Derek’s leg was amputated, the toe stopped sending signals. But the brain regions that had spent 34 years processing those signals — somatosensory cortex, posterior parietal cortex, anterior cingulate cortex — didn’t simply go dark. They kept operating, kept expecting, kept trying to make sense of an input stream that had been severed. And in the absence of normal input, they began hallucinating. Not metaphorically.

The brain literally generated pain output in the absence of the peripheral input that usually triggers it.

This understanding — pain as a brain-generated prediction rather than a faithful report of peripheral damage — is the foundation of modern pain neuroscience. It has a name: predictive processing, or predictive coding. Phantom pain, in a sense, is predictive coding running completely off its rails.


CORTICAL REMAPPING: THE BRAIN REORGANIZES AFTER LOSS

Vilayanur Ramachandran, the UC San Diego neuroscientist who has done more than anyone to illuminate phantom pain, stumbled onto a remarkable finding in the early 1990s that changed how the field understands the brain’s relationship to the body. He was working with a patient named Philip, who’d lost his left arm and experienced vivid phantom sensations, when he touched Philip’s cheek with a cotton swab. Philip felt the cotton swab on his cheek.

He also felt it on his phantom hand.

Not a fluke. Ramachandran tested multiple amputees and found the same pattern: touching the face or the stump consistently produced phantom limb sensations. Brain imaging confirmed the explanation — the somatosensory cortex, the brain’s body map, where each body region corresponds to a patch of cortical real estate, had reorganized.

The cortical territory that had once processed signals from the missing arm was being colonized by neighboring regions, particularly the face map, which sits adjacent to the hand map in the cortex. Signals from the face were now activating both the face representation and the old arm territory.

This phenomenon — cortical remapping, neuroplasticity in response to deafferentation, loss of sensory input — has been confirmed in dozens of subsequent studies using fMRI, MEG, and TMS. The degree of remapping correlates directly with phantom pain intensity. The more the cortex reorganizes, the more painful the phantom tends to be.

Conversely, people who retain more normal processing in the deafferented cortical area — either from useful sensory input via a prosthesis, or from interventions preventing reorganization — tend to report less severe phantom pain.

This remapping shows up across multiple brain systems, not just the somatosensory cortex. Motor cortex, posterior parietal cortex (body schema), thalamus, anterior cingulate cortex — all show altered activity following limb loss. Pain processing in phantom pain isn’t a single circuit running hot. It’s a whole-brain reorganization around the absence of a limb.


THE NEUROMATRIX: MELZACK’S RADICAL THEORY OF SELF

Ronald Melzack, who co-developed the Gate Control Theory of pain in 1965 and spent the following decades refining our understanding of how pain works, proposed in 1989 a theory he called the neuromatrix. One of the more intellectually ambitious frameworks in pain neuroscience, still.

Melzack’s argument, basically: the brain contains a genetically pre-wired neural network — the neuromatrix — generating a characteristic pattern of neural output he called the neurosignature. That output produces the sense of a unified, embodied self. It integrates sensory, cognitive, emotional, and motivational inputs but can generate output, including pain, even without those inputs. The body, in Melzack’s framework, is a construction of the brain. Not the other way around.

Phantom pain was the evidence that made the theory persuasive. People born without limbs — congenital amputees — sometimes report vivid phantom sensations of the missing limb. They’ve never had sensory input from that limb. There’s no peripheral memory for the brain to replay. Yet the neuromatrix generates the limb anyway, complete with sensation, sometimes pain.

Only explicable if the brain has a template for the body that’s partially independent of actual sensory experience — a genetically pre-wired expectation of having a body with a specific form.

The neuromatrix theory has been criticized for being hard to test empirically, and modern predictive coding frameworks have largely superseded it as an explanatory model. But Melzack got the fundamental insight right: the brain generates the body, not the reverse. And when the body changes — through amputation, injury, disease — the brain’s model struggles to update. That mismatch between model and reality is where phantom pain lives.


MIRROR THERAPY: TRICKING THE BRAIN WITH REFLECTIONS

flowers, mirror, reflection, reflected, bloom, flower background, spring, If phantom pain is a mismatch between the brain’s body model and actual bodily reality, the logical treatment is closing that mismatch — giving the brain visual feedback that the missing limb is real and moving normally. Ramachandran proposed exactly this in the mid-1990s, and the resulting treatment, mirror therapy, is simultaneously one of the simplest and most conceptually profound interventions in modern neurology.

The original mirror box is almost embarrassingly low-tech: a cardboard box, mirror mounted vertically in the middle. The patient inserts the intact hand on the mirror-reflecting side and the stump (or phantom limb side) on the other. Looking at the mirror, they see what appears to be their missing hand — actually the reflection of the intact one. Moving the intact hand, the visual cortex registers what looks like the missing hand moving.

The results, when they work, are immediate and dramatic. Ramachandran’s first patient, Phil, who had a clenched phantom fist that felt like nails digging into his phantom palm, moved his intact hand to an open position while watching the mirror. Immediate sensation of unclenching in the phantom hand. The imaginary nails released. Years of pain reduced within minutes.

Multiple randomized controlled trials have since validated mirror therapy for phantom limb pain, systematic reviews showing significant pain reductions versus control conditions. A 2016 Cochrane review found moderate-quality evidence supporting its effectiveness, though it noted heterogeneity across studies and called for larger trials.

The mechanism, current understanding suggests, involves the visual input of the reflected limb updating the brain’s motor prediction system — showing the motor cortex that its movement commands are having the expected effect, reducing the mismatch signal that generates pain.

Not everyone responds, and the effects can fade over time. But its existence and effectiveness confirm predictive coding’s fundamental prediction: you can treat brain-generated pain by changing what the brain sees, not just what the peripheral nervous system signals.


GRADED MOTOR IMAGERY: EVOLVING THE APPROACH

Mirror therapy works by providing visual feedback of movement. But researchers, particularly physiotherapist Lorimer Moseley and colleagues at the University of South Australia, realized that for some patients — particularly those with severe central sensitization — even imagining movement in the affected limb before seeing it in a mirror feels too threatening for the brain to tolerate.

They developed a more graduated protocol called graded motor imagery (GMI), now the gold standard for complex regional pain syndrome and holding strong evidence in phantom pain too.

GMI runs in three stages. First: limb laterality recognition — patients shown photographs of hands (or feet, or other body parts) and asked to identify which side, left or right, they’re looking at. Trivially easy for healthy people. For patients with phantom pain or CRPS, it activates the body-schema regions and is often painful or distressing. The task itself recalibrates how the brain represents the affected region.

Second: motor imagery — mentally rehearsing movements of the affected or phantom limb without actually moving. Activates motor planning circuits without requiring actual movement output, gradually restoring the brain’s willingness to engage the affected region. Third: mirror therapy itself, by which point the brain is more prepared to accept the visual feedback without triggering a defensive pain response.

A randomized controlled trial in The Lancet in 2004 found 12 weeks of GMI reduced pain and disability in phantom limb pain and CRPS significantly more than active control conditions. A 2017 meta-analysis of 12 studies confirmed GMI’s efficacy for both. The therapeutic logic holds up: you’re not managing pain symptoms. You’re retraining the brain’s body model to accurately represent the changed physical reality.


VIRTUAL REALITY: THE NEXT FRONTIER OF PERCEPTUAL RECALIBRATION

If a cardboard mirror box can reduce phantom pain by manipulating visual feedback, what could an immersive virtual reality environment accomplish? That question has driven one of the more exciting research programs in pain neuroscience over the past decade, and the early results are striking enough that the U.S. Department of Defense — facing a significant phantom pain burden in veterans — has invested substantially in VR pain research.

The basic VR approach augments mirror therapy: instead of a reflected image, the patient sees a virtual limb occupying the space where the missing limb would be. Modern VR systems can track the movements of electrodes on the residual limb, or on the intact contralateral limb, and translate them into real-time movements of the virtual limb.

The visual-motor coupling is tighter than anything a cardboard mirror can achieve, and the immersive environment may more effectively engage the predictive processing systems responsible for phantom pain.

A 2019 study in Neurology found VR mirror therapy reduced phantom limb pain by an average of 36% in combat veterans — a notoriously treatment-resistant population — compared to 14% in a control condition. More impressively, fMRI data from a subset of participants showed the VR treatment reduced cortical reorganization in the somatosensory cortex: the remapping that had occurred after amputation was partially reversed.

First strong evidence that a non-pharmacological intervention can actually undo cortical reorganization associated with phantom pain.

The mechanism appears to involve what researchers call “embodiment” — the degree to which the brain accepts a virtual body part as its own. Higher embodiment ratings correlate with larger pain reductions, suggesting the therapeutic effect depends not just on showing the brain a moving virtual limb but on convincing the brain the virtual limb is real.

The Rubber Hand Illusion — where participants accept a rubber hand as their own through synchronized tactile and visual stimulation — demonstrates that the brain’s body ownership system is surprisingly easy to manipulate. VR for phantom pain is essentially weaponizing that manipulability for therapeutic purposes.


THE SPINAL CORD AND GATE CONTROL: AMPLIFIERS IN THE PATHWAY

spine center in fremont, spine, doctor, patient, backpain, spinelcord, The brain generates phantom pain, but the spinal cord plays a critical amplifying role that helps explain why phantom pain is often so severe, and why standard analgesics so often fail to control it. Melzack and Wall’s 1965 Gate Control Theory proposed that pain signals can be “gated” in the spinal cord by competition between different types of nerve fibers.

But the story runs more complex than the original gate model suggested, particularly around deafferentation pain.

When peripheral nerves are cut — as in amputation — the severed nerve ends don’t simply go silent. They develop pathological spontaneous firing: ectopic discharges from damaged axons and reorganized dorsal root ganglia. These phantom signals travel to the spinal cord, activating wide-dynamic-range (WDR) neurons. With repeated activation, WDR neurons undergo wind-up: firing threshold drops, response magnitude increases, and they start responding to stimuli that would normally sit below threshold.

Spinal central sensitization. The dorsal horn amplifier turned up too high.

NMDA receptors play a central role in wind-up and spinal sensitization. Ketamine, an NMDA receptor antagonist, provides measurable relief in some phantom pain patients, confirming the spinal sensitization component. Gabapentin and pregabalin, which reduce ectopic discharge from damaged nerves by blocking voltage-gated calcium channels, have demonstrated efficacy in phantom pain across multiple trials — their mechanism targets the peripheral generator of the aberrant spinal input.

Dorsal root ganglion (DRG) stimulation — an emerging neuromodulation technique delivering electrical stimulation directly to the cluster of sensory neurons near the spinal cord — has shown significant promise in phantom pain that’s failed conventional treatment. A 2019 case series demonstrated 65-80% pain reduction in phantom limb pain following DRG stimulation, benefits persisting at 12-month follow-up. The specificity of DRG stimulation — it targets specific dermatome levels — allows more precise targeting than traditional spinal cord stimulation.


NEURAL INTERFACES AND MOTOR FEEDBACK: CLOSING THE LOOP

The most ambitious approach to phantom pain doesn’t just manipulate the brain’s visual inputs. It provides actual sensory feedback from a functional prosthetic limb, giving the brain the real-time proprioceptive and tactile information it lost at amputation. This is the domain of neural interfaces, and recent advances have produced results that would have read as science fiction a decade ago.

In 2020, researchers at the Max Planck Institute published results from a decade-long study of a patient called Karin, who’d received a “bionic hand” — a myoelectric prosthesis connected to sensory feedback electrodes implanted in the median and ulnar nerves. The device not only translated her muscle signals into hand movements but sent tactile feedback signals back through the implanted electrodes. Over seven years, Karin reported near-complete elimination of phantom pain.

MRI scans showed the cortical remapping associated with her amputation had largely reversed. The brain’s body map had been restored toward its pre-amputation organization.

A profound result. It demonstrates that phantom pain driven by cortical reorganization can be durably reversed by giving the brain appropriate sensory inputs — that the remapping, while persistent without intervention, isn’t permanent. The plasticity that allowed pathological reorganization after limb loss can be harnessed to restore normal organization when given the right inputs.

Less invasive approaches using targeted muscle reinnervation (TMR) — surgically reconnecting residual nerve endings to nearby muscles, restoring some degree of neural communication through the body — have also shown reductions in neuroma pain and phantom pain. The common principle across all these approaches: giving the deafferented nervous system meaningful afferent input reduces the pathological reorganization driving phantom pain.


PHANTOM PAIN IN NON-AMPUTATION CONTEXTS

Phantom pain research illuminates mechanisms relevant far beyond amputation. Any condition involving deafferentation — loss of sensory input to central pain systems — can produce phantom-like pain. And these conditions are far more common than amputation.

Spinal cord injury patients frequently experience pain below the level of their injury, in body regions from which they receive no sensory input at all. The mechanisms are identical to those in amputees: cortical reorganization, central sensitization, ectopic discharges from damaged nerve ends, pain output generated in the absence of nociceptive input.

The same predictive coding framework applies: the brain’s model of the body below the injury level doesn’t update to reflect the loss of input. It generates pain in expectation of normal sensation that never arrives.

Complex regional pain syndrome (CRPS) — a devastating chronic pain condition typically following limb injury — shows brain changes nearly identical to phantom pain. The affected limb is present, but it stops “belonging” to the brain in a functional sense: patients frequently report the limb feels foreign, doesn’t feel like their own, and that merely looking at it can be threatening.

The cortical representation shrinks, remaps, and the limb effectively becomes phantom-like in the brain’s representation. Treatments that restore normal cortical body schema — GMI, mirror therapy, specific forms of tactile desensitization — are effective in CRPS partly through the same mechanisms that work in phantom pain.

Even chronic back pain — the most prevalent pain condition globally — shows cortical reorganization resembling deafferentation phenomena. The chronic back pain patient’s somatosensory representation of the back region is reduced in size and precision compared to healthy controls, and the magnitude of that reduction correlates with pain severity and duration.

Treatments restoring normal sensory maps — graded sensory discrimination training, specific movement therapies — have demonstrated efficacy in chronic back pain not explained by biomechanical factors alone.


PHARMACEUTICAL APPROACHES: WHY STANDARD ANALGESICS OFTEN FAIL

pill, medicine, capsule, pain, antibiotic, medication, prescription, health, Phantom pain has one of the worst pharmaceutical treatment records in all of pain medicine. Standard analgesics — opioids, NSAIDs, acetaminophen — have consistently underperformed in clinical trials. Understanding why is instructive about both phantom pain specifically and centrally mediated pain generally.

Opioids, designed to reduce nociceptive signaling, work poorly when the primary pain generator isn’t nociceptive activity in peripheral tissues but abnormal neural processing in a remapped central nervous system. You can’t significantly reduce the output of a pathologically reorganized brain by blocking a receptor pathway designed for normal pain signaling. The signal being amplified isn’t coming from where the drugs are aimed.

Worse, chronic opioid use promotes glial activation and neuroinflammation in the spinal cord — a process that paradoxically increases central sensitization over time, potentially worsening phantom pain the longer it’s used.

Tricyclic antidepressants (TCAs) like amitriptyline have shown modest efficacy in some trials, working through sodium channel blockade (reducing ectopic nerve discharge), NMDA receptor modulation, and central noradrenergic pathways. Gabapentinoids (gabapentin and pregabalin) carry the strongest evidence base among pharmacological options, though effect sizes in randomized trials are moderate, not dramatic. Ketamine infusions show acute analgesic effects through NMDA blockade but require repeated administration and carry substantial side effect profiles.

Calcitonin — a peptide hormone involved in calcium metabolism — showed early promise in phantom pain and remains on some treatment guidelines, though its mechanism of action is unclear and more recent trials have been less convincing. Botulinum toxin injected into the stump has shown benefit in some case series, possibly through effects on peripheral nerve endings that reduce ectopic discharge.

The pattern across pharmacological approaches holds consistent: the more centrally acting the drug — the more it addresses neural processing rather than peripheral signal — the better it tends to perform in phantom pain. A clinically important signal about where the pathology actually lives.


THE IMPLICATIONS FOR ALL CHRONIC PAIN

Derek eventually found relief through a combination of GMI, mirror therapy, and gabapentin, though his phantom sensations never fully disappeared. What changed was his relationship to them — and, crucially, his understanding of them. When he understood that his phantom foot was his brain’s construction rather than a mysterious spiritual remnant or evidence of unfixable nervous system damage, the experience shifted. He couldn’t will the sensations away.

But he could reframe them as information about a nervous system still trying to protect a body part it thought he had. That shift — from “my absent foot is destroying me” to “my brain is working very hard on a problem I need to help it solve differently” — was itself therapeutic.

This is the deepest implication of phantom pain neuroscience for all chronic pain: pain is a protective output generated by the brain when it perceives threat. In normal acute pain, that’s adaptive — it keeps you from using an injured limb, drives you to seek help, motivates healing. In chronic pain, the threat-detection system has become miscalibrated, generating protective output (pain) in the absence of tissue damage that warrants it.

The treatment challenge, across all chronic pain, isn’t just reducing pain signals. It’s recalibrating the threat-detection system itself — helping the brain update its model of the body and reassess its threat predictions.

Phantom pain makes this abstract principle concrete in the starkest possible way. There’s no tissue to fix. No peripheral source to address. Only the brain, generating pain in service of a body model that no longer matches reality. And the treatments that work — mirror therapy, GMI, VNS, neural interfaces — work by changing the brain’s model, not the body.

This is the future of chronic pain treatment: not more powerful drugs to silence signals, but more sophisticated approaches to recalibrate the neural systems generating pain in the first place.


Pain Not Where Q&A

Why do some amputees feel no phantom pain while others experience it severely?

Several factors predict phantom pain severity. Pre-amputation pain in the affected limb is one of the strongest predictors — the longer and more severe the pre-existing pain, the more the brain’s pain-processing network has organized around that pain signal, and the more likely it is to keep generating it after amputation.

Psychological factors including anxiety, depression, and catastrophizing also correlate strongly with phantom pain severity — consistent with the predictive coding model, where affective and cognitive states shape the brain’s threat assessment and therefore its pain output. Interestingly, epidural anesthesia during and after amputation, by blocking pain signals during the critical post-amputation period, reduces phantom pain incidence — suggesting what happens to the nervous system in that immediate window is critical for long-term outcomes.

Can phantom limb pain occur in non-amputation situations?

Yes, more commonly than most people realize. “Phantom” sensations occur after mastectomy (phantom breast pain in 20-30% of patients), tooth extraction (phantom tooth pain), and eye removal (phantom eye pain). Spinal cord injury produces pain below the level of injury through mechanisms closely related to phantom limb pain. Any nerve injury producing complete or partial deafferentation can produce phantom-like pain through cortical reorganization and central sensitization.

People with congenital limb absence — born without a limb — can also experience phantom limb sensations, demonstrating that peripheral sensory experience isn’t required for the brain’s limb representation to generate phantom outputs.

Does mirror therapy work for everyone?

No, and predicting who responds remains an active research question. Response rates in clinical trials typically run 50-75%, a substantial non-responder group. One key factor: the ability to generate a clear motor image — some patients, particularly those with severe central sensitization, find that imagining movement of the phantom limb triggers pain rather than relieving it.

For these patients, graded motor imagery’s progressive approach — starting with laterality recognition before attempting motor imagery or mirror work — appears more appropriate. The degree of cortical reorganization may also modulate response — patients with more extensive remapping may need more intensive or longer treatment for the same benefit.

What role does psychology play in phantom pain?

Psychology plays a central role, though not in the dismissive “it’s psychological” sense historically used to invalidate pain patients. Catastrophizing — interpreting pain as the worst possible and unmanageable — is one of the strongest predictors of phantom pain intensity and disability, independent of amputation severity. CBT targeting catastrophizing and pain-related fear has demonstrated significant reductions in phantom pain in randomized trials.

Acceptance and commitment therapy (ACT), which focuses on changing the relationship to pain rather than eliminating it, has shown similar efficacy. These psychological interventions appear to work by modulating the brain’s threat assessment — reducing the affective valence attached to phantom sensations and, with it, the pain output that accompanies them.

Are there new treatments on the horizon that might eliminate phantom pain entirely?

Several promising approaches are in active clinical investigation. Osseointegrated implants — titanium fixtures fusing with residual bone and transmitting sensory vibration through the skeleton — combined with neural interfaces are being tested in Scandinavia with early evidence of dramatic pain reductions and improved prosthetic control. Closed-loop brain stimulation systems that monitor cortical activity in real time and deliver targeted stimulation when pain-related patterns appear are in early-phase trials.

Gene therapy approaches targeting the sodium channels responsible for ectopic nerve discharge are in preclinical development. Non-invasive brain stimulation techniques including transcranial magnetic stimulation (TMS) of the motor cortex have shown consistent analgesic effects across multiple phantom pain trials and may represent a practical near-term option for patients who don’t respond to established treatments.

PAIN NEUROSCIENCE EDUCATION: CHANGING BELIEFS CHANGES PAIN

One of the more remarkable and counterintuitive findings from phantom pain research — and chronic pain neuroscience broadly — is that educating patients about pain neuroscience itself reduces pain. Not as a placebo effect. Not merely by improving coping. By actually changing the brain’s threat assessment and, through that, reducing the pain output the assessment generates.

Lorimer Moseley and colleagues have run multiple trials examining the effect of pain neuroscience education (PNE) — structured teaching about how pain works, what drives central sensitization, why the brain generates pain in the absence of tissue damage — on chronic pain outcomes.

A 2004 study in The Spine Journal found patients with chronic low back pain who received intensive pain neuroscience education showed larger reductions in pain, disability, and healthcare utilization at 12-month follow-up than those who received anatomical education about the back. The patients who understood pain better hurt less.

In phantom pain, this principle is especially potent because the gap between the experience and a patient’s intuitive understanding is so dramatic. Most amputees, and plenty of clinicians, conceptualize phantom pain as arising from “confused nerves” or “damage to the stump” — a peripheral problem needing peripheral solutions. Understanding that phantom pain is a brain-generated construction, that the cortex has reorganized and is running an outdated body model, fundamentally changes the psychological orientation to the experience.

It shifts from “something is wrong with my body that can’t be fixed” to “my brain has made an accurate map of my old body and needs help updating it.” That cognitive shift reduces catastrophizing, reduces fear-avoidance behavior, and — through top-down modulation of the pain matrix — reduces pain itself.

Derek’s story ends here, essentially. He didn’t get surgery. He didn’t receive a neural interface. He learned how his brain worked, practiced mirror therapy daily for three months, started graded motor imagery, and gradually rebuilt his capacity to engage with the world without his nervous system constantly screaming at him about a foot that wasn’t there. The neuroscience didn’t just explain his pain. In explaining it, it began to change it.

The lesson extends beyond phantom pain to every chronic pain condition. When the brain understands it is constructing pain — that pain is a protective output designed to keep you safe, not an invariable readout of tissue damage — it loses some of its authority over your behavior. Not all of it. But enough to start changing the equation.

And in chronic pain, changing the equation even slightly can mean the difference between a life dominated by suffering and a life lived in its presence but not consumed by it.

Phantom pain is extreme in how it demonstrates this principle, but it isn’t unique. Every person with chronic pain has a brain running a model of their body that may be inaccurate, amplified, or miscalibrated. The future of pain treatment — and the present, for those willing to engage with the evidence — is the science of updating that model. Phantom pain research pointed the way. The rest of pain medicine is following.


The Practical Framework: Applying Pain Where Think In Real Life


References


Tags


You may also like

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Get in touch

Name*
Email*
Message
0 of 350